Related Experiment Video
Updated: Jul 19, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Natural killer cells: from bench to cancer therapy
Michael Boyiadzis1, Kenneth A Foon
1University of Pittsburgh Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, UPMC Cancer Pavilion, 5150 Centre Avenue, Suite 572, Pittsburgh, PA 15232, USA. boyiadzism@upmc.edu
Abstract:
Natural killer (NK) cells are effectors of the innate immune system that play an important role in host response against viruses and tumour cells through the production of cytokines and direct cytolytic activity. There has been limited success reported from clinical trials in cancer patients treated with activated NK cells. Over the last decade, a better understanding of the biology of NK cells, NK cell receptors and the role of interleukin-15 has led to the development of new strategies using NK cells as immunotherapy for cancer treatment in the transplant and non-transplant settings.
Insights
Natural killer (NK) cells are crucial for fighting viruses and tumors. Recent advances in understanding NK cell biology and interleukin-15 are paving the way for improved NK cell immunotherapies in cancer treatment.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- Natural killer (NK) cells are key components of the innate immune system.
- NK cells combat viral infections and tumors via cytokine production and direct cell killing.
- Previous clinical trials using activated NK cells for cancer yielded limited success.
Purpose of the Study:
- To explore novel strategies for cancer immunotherapy utilizing NK cells.
- To leverage advancements in NK cell biology and receptor function.
- To investigate the role of interleukin-15 in enhancing NK cell activity for therapeutic purposes.
Main Methods:
- Reviewing recent developments in NK cell biology and receptor signaling.
- Analyzing the impact of interleukin-15 on NK cell activation and function.
- Evaluating new therapeutic strategies in both transplant and non-transplant settings.
Main Results:
- A deeper understanding of NK cell mechanisms has emerged.
- Interleukin-15 has been identified as a critical factor in NK cell-mediated immunity.
- New therapeutic approaches are being developed based on these findings.
Conclusions:
- Enhanced knowledge of NK cell biology is driving innovation in cancer immunotherapy.
- Targeted strategies involving NK cells show promise for treating cancer.
- Further research is ongoing to optimize NK cell-based therapies.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
